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Both chronic pain and obesity are known to a-ect reproductive hormone pro.les in male patients. However, the e-ect of these
conditions, alone or in combination, on male fertility potential has received less attention. 20 chronic musculoskeletal pain
patients and 20 healthy controls were divided into lean and overweight subgroups according to their BMI. Current level of chronic
pain (visual analogue scale) and pressure pain thresholds (PPTs) in 16 prede.ned sites, classically described and tested as painful
points on the lower body, were measured. Levels of reproductive hormone and lipid pro.les were assessed by ELISA. Sperm
concentration and motility parameters were analyzed using a computer-aided sperm analysis system. Sperm concentration,
progressive motility, and percentage of hyperactivated sperm were generally lower in the chronic pain patients in both lean and
overweight groups. )e overweight control and the lean chronic pain groups demonstrated a signi.cantly lower percentage of
progressively motile sperm compared with the lean control group, suggesting that musculoskeletal chronic pain may have
a negative in:uence on sperm quality in lean patients. However, due to the potential great negative in:uence of obesity on the
sperm parameters, it is di<cult to propose if musculoskeletal chronic pain also in:uenced sperm quality in overweight patients.
Further research in chronic pain patients is required to test this hypothesis.
1. Introduction
Male factor infertility accounts for approximately 40% of
infertility cases [1, 2]. Assessment of semen quality is the .rst
step in assessing male factor infertility [3, 4] and depends on
several parameters including semen volume, sperm con-
centration, total count of spermatozoa, motility, vitality, and
morphology [5]. Increased BMI has been suggested to
negatively a-ect spermatogenesis and the molecular struc-
ture of germ cells in the testis and sperm maturation in the
epididymis [6, 7], consequently resulting in reduced sperm
quality and male subfertility [8–12].
)e World Health Organization (WHO) de.nes over-
weight and obesity as excessive or abnormal fat accumula-
tion, which impairs health [13].)e body mass index (BMI) is
the most frequently used assessment for overweightness and
obesity [14]. )e WHO has de.ned a BMI greater than
25 kg/m2 as overweight and a BMI greater than 30 kg/m2 as
obese [15].
In contrast to the extensive attention paid to the e-ect of
obesity on many health-related issues, the impact of obesity
on reproduction has received less attention [8, 9]. Obesity
has been reported to increase the conversion of androgens
to estradiol, leading to elevated levels of serum estrogen;
the increased estradiol in turn impacts the hypothala-
mus, causing stimulation of GnRH, to release FSH and LH,
resulting in reduced testicular function and reduced pro-
duction of testosterone (both intratesticular and circulating
testosterone) [8]. Infertile men have demonstrated a lower
testosterone and higher estradiol levels compared with fertile
men, which may be due to the gonadotropin suppression by
estradiol and can be considered as a common marker for
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fertility potential in men [16]. It is also suggested that ex-
cessive estradiol has a direct negative e-ect on spermato-
genesis [8, 16].
)e role of reproductive hormones in pain is not well
understood. Many hormonal e-ects on pain which were ini-
tially thought to be due to gonadal release of the hormone may
actually be due to the hormone synthesis in tissues such as the
brain and spinal cord (e.g., progesterone and estradiol). Many
of the central regions implicated in pain and analgesia contain
receptors for both estrogens and androgens and have the ability
to synthesize steroids locally. Binding of speci.c steroids to
their receptors within these central and peripheral regions is
likely involved in ligand-dependent transcriptional events,
thereby in:uencing the expression of various neurotransmit-
ters and receptors. It has been suggested that sex steroids have
profound e-ects not only on developmental organization but
also on the ongoing dynamics of the nervous system [17, 18].
Musculoskeletal disorders (MSDs) are generally associ-
ated with pain due to a sensory disturbance, caused by
proin:ammatory conditions [7]. )e development and
progression of the MSDs are thought to be through increased
mechanical load and alteredmetabolic and hormonal changes
driven by overweightness and obesity [13, 19]. A full un-
derstanding of the pathological mechanisms underlying the
e-ects of obesity on musculoskeletal disorders requires fur-
ther investigation [7, 19].
Neuroplasticity is the alteration of neural pathways and
synapses due to changes in behavior, environment, and
neural process as well as changes resulting from physical
injury like obesity [19–21]. Neuroplasticity can also result in
the change of nerve cells, pain receptors, and the sur-
roundings of the nerve signal due to the release of in-
:ammatory substances associated with primary tissue
damage [20–22]. McVinnie suggested that pain and obesity
are more often two sides of the same coin as chronic pain can
also lead to obesity because of inactivity or perhaps a genetic
factor contributing to both [19].
Obesity can a-ect chronic pain, and a link between obesity
and semen quality exists. Considering that both obesity and
chronic pain can a-ect the reproductive hormonal pro.les in
male patients, this study aimed to assess and compare re-
productive hormones and semen quality in overweight and
normal weight chronic pain patients and healthy controls to
provide a deeper insight into the possible relation between
obesity, chronic pain, and male fertility potential.
2. Materials and Methods
)is study was performed at the orthopedics department,
Aalborg University Hospital, and Fertility Clinic in Dron-
ninglund, Denmark, from June 2014 to December 2015,
following approval from the Scienti.c Ethics Committee of
the Northern Jutland Region, Denmark (approval reference
no. N-20140025).
2.1. Study Population. Patients attending the orthopedics
department of Aalborg University Hospital (Aalborg,
Denmark), with a history of at least 3 months of low back
pain and lower extremity chronic pain with a minimum
score of three on the visual analogue scale (VAS), were
considered and invited by the study healthcare professional
to take part in this study as the test group. Healthy volunteers
with no previous history of chronic musculoskeletal pain
were also recruited frommales visiting the clinic for checkups
or as accompanying persons. Age (18–46 years) and BMI
(lean< 25 kg/m2< overweight) were initially considered to
recruit a su<cient number of patients for all study groups.
All participants provided written consent and .lled
a questionnaire describing the history of the chronic pain
and information regarding possible confounding factors
(i.e., medication, reproductive surgery, or complications),
which were taken into account for the patients’ inclusion and
assessment of results. Based on the approved protocol,
participants using medications including strong analgesics
(e.g., opioids), having an ongoing infection, with current or
previous neurologic, musculoskeletal, or mental illnesses,
malignancy, drug addiction (cannabis, opioids, or other
psycho drugs), reproductive surgery, and related compli-
cations were not included in the study.
Height and weight were measured to calculate the body
mass index (BMI). A BMI≥ 25 kg/m2 was considered as
overweight in this study. Recruitment was continued until
each of the chronic pain and control groups had equal
numbers (10) of participants in the overweight and lean
groups (determined based on BMI).
)e subgroups (2× 2 design) based on BMI and pain
status (10 patients in each group) are as follows:
(i) Overweight patients with chronic pain (OP)
(ii) Overweight patients without chronic pain (OC)
(iii) Lean patients with chronic pain (LP)
(iv) Lean patients without chronic pain (LC).
)emean (±SD) andmedian (min–max) age and BMI of
the participants have been demonstrated in Table 1. Figure 1
illustrates the order of the performed tests and procedures in
a schematic timeline.
2.1.1. Pain Intensity and Quality Assessment. )e chronic
pain patients were asked to rate their minimum and max-
imum pain intensity at rest condition during the previous
three months, by marking on a 10 cm horizontal visual
analogue scale (VAS) of 0–10 (0 “no pain”; 10 “the most
pain imaginable”). )e updated Short Form McGill Pain
Questionnaire (SF-MPQ-2) [23] was used to assess the pain
quality. )e total score and its 4 subscale scores (continuous
pain, intermittent pain, predominantly neuropathic pain,
and a-ective descriptors) of the SF-MPQ-2 questionnaire
have been validated as a reliable, valid, and responsive tool
for the assessment of pain in patients with chronic pain,
acute low back pain, and associated radicular leg pain [24]. A
body chart was also provided to each subject in order to
mark the distribution area of perceived pain.
2.1.2. Mechanical Pain reshold Assessment. Quantitative
sensory testing paradigms such as pressure pain threshold
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(PPT) mapping by dynamic pressure algometry have been
used to assess the functional status of the excitability of the
pain system and to describe mechanical pain sensitivity in
larger areas of the body covering one or more muscles
[25–27]. Mechanical pain thresholds were assessed in both
chronic pain and control groups by a handheld pressure
algometer (Somedic, Sweden) in predened points, which
have been classically described and tested as painful areas
[28, 29] (Figure 2), and one reference point located on the
upper arm of the nondominant hand which was not aected
by the pathogenesis of the disease [30] was considered for
pressure pain threshold (PPT) measurements.
A gradually increasing pressure was applied to the
predened points by the investigator, while subjects were
instructed to press the stop button to record the PPT at “the
point where the pressure sensation just becomes painful.” A
display on the algometer aided the investigator to deliver
a constant increasing pressure (30 kPa/s), with the algometer
tip (1 cm2 probe area) applied perpendicularly at the stim-
ulation site. e procedure was repeated three times with an
interval of 1min for all test points. Averages of the three
repetitions were considered as the subject’s PPT for each
test point and used for further analysis.
2.1.3. Blood Sampling for Proling Serum Lipids and Re-
productive Hormone Levels. All participants were asked to
fast for ≥12 hours prior to attending the assessment ses-
sions. Blood samples from all participants were collected
from the median cubital, cephalic, or basilic veins by an
experienced technician at the laboratory of clinical bio-
chemistry at Aalborg University Hospital (Aalborg, Den-
mark) and assessed for lipid proles (triglyceride, total
cholesterol, LDL, VLDL, and HDL), luteinizing hormone
(LH), and follicle-stimulating hormone (FSH) according to
the routine protocols. Testosterone levels were analyzed
and reported by the “Statens Serum Institut (SSI)”
(Copenhagen, Denmark).
2.2. Semen Collection and Analysis. Semen samples were
collected by masturbation and allowed to liquefy for 30–45
minutes at room temperature. Following liquefaction, the
total volume of each sample was measured using a graduated
pipette, before being divided into three parts to be used for
the following assessments.
2.2.1. Concentration,Motility, andKinematic Parameters. Five
microliters of the liqueed sperm suspension was loaded
into a “Leja chamber slide” (20 μm deep) (Leja Products
B.V., Nieuw-Vennep, Netherlands) and placed on a temper-
ature-controlled stage (37°C) of the Nikon E50i microscope,
equipped with a 10× positive phase-contrast objective (total
magnication of 100x) in conjunction with a phase-contrast
condenser and a Basler sca780 (Basler, Germany) camera.
Samples were assessed for concentration and motility (kine-
matic parameters) using the motility/concentration module of
the Sperm Class Analyzer (SCA®, Ver. 5.4, Barcelona, Spain)
computer-aided sperm analysis (CASA) system.
e SCA motility module provided detailed velocity and
motion-path kinematic parameters. e default cuto
values of the SCA were used to assess the following motion
parameters as also specied by the WHO (WHO [31]):
curvilinear velocity (VCL, μm/s), straight line velocity
(VSL, μm/s), average path velocity (VAP, μm/s), amplitude
of lateral head displacement (ALH, μm), linearity (LIN),
wobble (WOB), straightness (STR), and beat-cross fre-
quency (BCF, Hz) dened at 50 fps. Based on these assess-
ments, the sperm motility was classied as rapid (VCL>
25 μm/s), medium (25<VCL< 5), slow (VCL< 5), and im-
motile (VCL 0 μm/s) and sperm progression as progressive
Table 1:e age and BMI (body mass index) of the participants in the study groups. Multivariate two-way analysis of variance (MANOVA)
was used to compare dierences in BMI and age.
Age (years) BMI
Mean± SD Median (min, max) Mean± SD Median (min, max)
OP 30.8± 9.7 30 (18, 46) 29.7± 5.2 27.9 (25.2, 41.4)
OC 26.1± 3.8 25 (22, 33) 26.2± 1.5 25.6 (25.1, 29.8)
LP 27.6± 5.4 26 (19, 36) 23.7± 1.3 24.4 (20.9, 24.7)
LC 25.9± 6.9 23 (19, 42) 22.4± 0.5 22.4 (21.3, 22.9)
BMI: body mass index (kg/m2); OP: overweight with chronic pain; OC: overweight control; LP: lean with chronic pain; LC: lean control (N 10 per group).
Recruitment of
healthy
volunteers and
chronic pain
patients 
Pain intensity and
quality questionnaire
(Calculation of BMI,
collection of general
information and
assessment of possible
confounding factors) 
Mechanical pain
threshold
assessment
(PPT: pressure
pain threshold)
Blood sampling 
(>12 h fasting)
profiling serum
lipids and
reproductive
hormone levels
Semen sample
collection
Sperm quality
assessment using
computer-aided
sperm analysis
Figure 1: Schematic timeline demonstrating the order procedures performed in the study.
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motile (PM, STR> 80%), nonprogressive motile (NPM, 80%
> STR> 0%), and immotile (immotile, STR 0%).
)e percentage of hyperactivated spermatozoa was
assessed based on the VCL, LIN, and ALH parameters at
50 fps.
2.2.2. Morphology. Air-dried sperm smears were prepared
and stained using “Spermblue” (Microptic S/L, Barcelona,
Spain) according to the manufacturer’s instructions (10
minutes in .xative solution followed by 10 minutes in sperm
blue stain) before being assessed using the morphology
module of the SCA (automatically quanti.ed measurements
of sperm head and midpiece) at 1000x magni.cation.
2.2.3. DNA Fragmentation (Halosperm Kit). )e DNA
fragmentation of the samples was assessed using the
Halosperm kit (Halotech, Madrid, Spain) according to the
manufacturer’s instructions. In general, un.xed sperm
cells are immersed in an agarose microgel on a slide in-
cubated in an acid unwinding solution that transforms
DNA breaks into single-stranded DNA, followed by im-
mersion in a lysing solution to remove protamines. After
staining, the spermatozoa without fragmented DNA show
stained nucleoids with big halos of spreading of DNA
loops, whereas those with fragmented DNA appear with
a small or no halo. )e halo sizes and fragmentation
index were assessed using the “SCA DNA fragmentation”
module.
2.2.4. Statistics. Data are shown as mean± standard de-
viation (SD) unless stated di-erently. All data were checked
for normal distribution, and parametric tests were applied.
For nonnormal cases, either the Kruskal–Wallis non-
parametric test was used or data were corrected using
logarithmic transformation prior to further assessments.
Multivariate two-way analysis of variance (MANOVA) was
used to compare di-erences in weight, lipid pro.le pa-
rameters (cholesterol triglyceride, HDL, and LDL), hor-
mones (LH, FSH, and testosterone), and semen kinematic
parameters in a full factorial model with pain group (pain
and no pain) and weight group (lean and overweight) as the
factors in this model. A P value of ≤0.05 was considered
signi.cant. )e “IBM® SPSS® Statistics” (Ver. 23, IBM, USA)
was used to perform statistical analysis.
Figure 2: )e anatomic sites for pressure pain threshold evaluations over the muscles, patellar tendon, pes anserinus bursae, and
supraspinous ligaments in the anterior, posterior, and lateral views. 1: vastus medialis muscle; 2: rectus femoris muscle; 3: vastus lateralis
muscle; 4: adductor longus muscle; 5: tibialis anterior muscle; 6: peroneus longus muscle; 7: patellar tendon; 8: pes anserinus bursae; 9:
popliteous muscle; 10: iliacus muscle; 11: quadrates lumborum muscle; 12: supraspinous ligaments, area between L5–S1 and S1–S2; 13, 14:
extensor digitorum brevis; 15: extensor hallucis longus; 16: :exor halluces longus; C: deltoids.
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3. Results
All participants completed the study and no safety issues
were reported or recorded following the procedures applied
in the study sessions.
3.1. Pain Intensity andQuality. Overweight and lean chronic
pain patients reported their minimum pain intensity levels
of 5.15± 2.21 and 4.7± 1.97 cm and maximum peak pain
intensities of 7.78± 1.97 and 8.01± 1.77 cm on the VAS,
respectively, which corresponded to their pain within the
last 3 months.
Figure 3 demonstrates the distribution of the pain in the
chronic pain patients. )e following terms were the most
reported (30%) descriptors of pain by the chronic pain sub-
jects: throbbing, shooting, boring, sharp, hot, taut, exhausting,
and grueling, blinding, and nauseating.
No statistically signi.cant di-erence in pressure pain
thresholds (PPTs) was observed in any of the assessed spots
between the subgroups. However, pain groups (LP and OP)
demonstrated a trend towards lower pain thresholds com-
pared with the control groups (LC and OC) (Table 2).
3.2. Semen Analysis
3.2.1. Concentration, Motility, and Sperm Kinematic
Parameters. Semen analysis parameters were assessed using
the SCA, and the results are summarized in Table 3.
Both lean and obese control groups demonstrated in-
signi.cantly higher mean concentrations compared with
their respective chronic pain groups.
)e LC group demonstrated a signi.cantly higher
percentage of progressively motile sperm (p  0.034)
and consequently a lower percentage of immotile and
nonprogressively motile sperm compared with the LP
group. )e percentage of sperm in the di-erent motility
categories in the OC and OP groups demonstrated a similar
trend however insigni.cant (Table 3).
Moreover, BMI demonstrated a signi.cant in:uence on
the percentage of sperm with progressively motility among
both lean and overweight groups (p  0.036) (Table 3). )e
interaction between pain and weight groups was signi.cant
for progressive motility (p  0.02), suggesting that the e-ect
of pain level on the percentage of progressively motile sperm
was di-erent between the di-erent weight groups.
Chronic pain demonstrated a signi.cant in:uence on
VCL, STR, and WOB in overweight patients, with signi.-
cantly decreased (p  0.049, p  0.025, and p  0.021, resp.)
values in OP compared with OC. )e LC group demon-
strated the same tendency when compared with LP; how-
ever, no statistical signi.cance was found (Table 4).
VCL also showed a signi.cantly (p  0.008) lower value
in the OC compared with the LC, while STR and WOB
demonstrated signi.cantly lower values (p  0.026 and
p  0.006) in the OP compared with the LP group. )e
interaction between pain and weight groups was signi.cant
for VCL, LIN, and WOB (p  0.02, p  0.05, and p  0.01,
resp.), suggesting that pain level a-ected these parameters
di-erently based on the weight group.
3.2.2. Morphology and DNA Fragmentation. )ere was no
signi.cant di-erence in the morphology and DNA frag-
mentation in lean and overweight chronic pain patients
compared with the healthy controls. Both lean and obese
chronic pain groups displayed a trend towards higher
percentage of DNA fragmentation and lower percentage of
normal morphology compared with the respective control
groups (Table 3), but the interaction level between pain and
(a) (b)
Figure 3: Superimposed pain distribution areas as indicated in OP (overweight chronic pain, (a)) and LP (lean chronic pain, (b)) patients.
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Table 2: Pressure pain threshold values in overweight pain patient (OP), overweight control patient (OC), lean pain patient (LP), and lean
control patient (LC) in 16 di-erent test points in the body. Provided values are mean± standard deviation. Multivariate two-way analysis of
variance (MANOVA) was used to compare di-erences in each parameter in pressure pain thresholds.
Group test point
LC LP OC OP
Mean Std. deviation Mean Std. deviation Mean Std. deviation Mean Std. deviation
p1: Vastus medialis muscle 386.29 134.97 231.84 103.78 366.24 155.36 211.37 154.97
p2: Rectus femoris 457.84 192.78 241.20 78.95 351.00 172.91 221.41 181.40
p3: Vastus lateralis muscle 369.40 221.56 227.64 82.77 325.52 210.58 190.75 177.75
p4: Adductor longus muscle 305.93 137.61 291.75 113.72 289.77 149.49 110.35 96.00
p5: Tibialis anterior muscle 355.74 197.83 244.14 107.21 277.60 161.21 178.05 149.39
p6: Peroneus longus muscle 404.23 198.05 247.66 102.08 304.76 174.70 227.83 144.37
p7: Patellar tendon 460.37 316.30 217.08 67.81 282.99 102.49 207.53 200.58
p8: pes anserinus bursae 316.84 174.43 225.36 82.27 276.56 155.86 200.82 112.23
p9: Popliteous muscle 332.07 197.19 272.26 90.40 295.79 161.76 244.15 168.62
p10: Iliacus muscle 399.08 91.24 244.86 133.52 318.13 135.21 228.00 149.85
p11: Quadrates lumborum muscle 283.61 124.37 233.43 66.02 254.01 186.66 227.16 102.97
p12: Supraspinous ligaments area
between L5–S1 and S1–S2 304.00 154.53 289.28 109.48 296.07 170.83 217.15 119.43
p13: Extensor digitorum brevis 252.22 73.37 207.25 96.08 230.14 104.66 183.10 90.70
p14: Extensor digitorum brevis 317.94 128.46 239.44 126.77 242.30 74.64 224.30 146.16
p15: Extensor hallucis longus 297.27 173.54 198.99 49.99 256.87 188.01 245.38 62.91
p16: Flexor halluces longus 252.70 148.90 235.00 116.33 257.00 93.43 190.20 55.60
Control: Deltoids 358.38 128.38 244.91 126.80 260.58 100.78 232.87 110.40
None of the ANOVA results are signi.cant.
Table 3: Sperm quality parameters in overweight with chronic pain (OP), overweight control (OC), lean with chronic pain (LP), and lean
control (LC). Provided values are median (25–75 percentiles), and superscripted letters mark pairwise signi.cant di-erences (p< 0.05).
Multivariate two-way analysis of variance (MANOVA) was used to compare di-erences in sperm quality parameters.
OP OC LP LC
Motility (WHO [31])
Concentration (m/ml) 37.4 (31.9–92.3) 63.9 (45.3–78.5) 16.2 (8.0–50.3) 49.8 (23.9–100.9)
Immotile (%) 22.3 (13.0–44.5) 28.9 (19.6–42.7) 40.9 (39–48.7) 29 (12.1–57.0)
Nonprogressive motile (%) 50.5 (31.3–62.6) 26.35 (23.7–32.8) 28 (23.9–34.075) 22.85 (16.9–25.5)
Progressively motile (%) 24.2 (23.3–25.0) 39.5 (26.1–57.7)b 29.7 (22.8–33.4)a 42.6 (22.7–66.7)a,b
Hyperactivated sperm (%) 5.15 (2.0–10.4) 12.6 (5.9–17.6) 4.1 (1.8–4.6) 10.7 (4.7–24.1)
DNA fragmentation (%) 41.7 (30.3–65.3) 41.3 (28.1–66.7) 55.4 (39.2–72.0) 29 (16.5–76.1)
Normal morphology (%) 3.7 (3.1–6.5) 5 (2.7–13.8) 8 (7.0–9.9) 13.1 (7.4–20.6)
Table 4: Median (25–75 percentiles) kinematic parameters of sperm motility in overweight with chronic pain (OP), overweight control
(OC), lean with chronic pain (LP), and lean control (LC) groups. Superscripted letters mark pairwise signi.cant di-erences (p< 0.05).
Multivariate two-way analysis of variance (MANOVA) was used to compare di-erences in kinematic parameters.
Average kinematic parameters OP OC LP LC
VCL (μm/s) 38.0 (27.2–39.4)a 42.8 (40.85–63.1)a,b 31.7 (28.4–36.3) 47.5 (31.1–54.1)b
VSL (μm/s) 14.5 (11.2–21.5) 18.7 (14.55–29.8) 11.4 (10.3–14.1) 17.6 (12.2–21.2)
VAP (μm/s) 20.9 (16.5–29.9) 25.5 (20.45–39.9) 17.0 (15.1–20.0) 24.2 (17.0–28.3)
LIN (%) 36.8 (31.6–43.9) 42.3 (35.6–46.0) 36.8 (34.5–40.1) 43.3 (36.8–46.8)
STR (%) 66.9 (63.1–72.8)a,b 73.3 (70.95–76.1)a 69.1 (63.5–70.8)b 75.0 (68.6–76.2)
WOB (%) 51.2 (45.0–54.8)a,b 57.3 (50.80–61.0)a 55.2 (53.2–56.3)b 56.8 (54.5–62.4)
ALH (μm) 2.8 (2.6–3.8) 3.2 (2.90–3.3) 2.5 (2.30–3.0) 2.6 (2.3–2.9)
BCF (HZ) 5.1 (3.8–6.2) 6.5 (5.9–6.7) 4.8 (4.5–5.0) 5.6 (4.9–6.1)
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weight groups was not signicant for morphology or DNA
fragmentation parameters (p  0.88 and p  0.20, resp.).
3.3. Blood Serum Lipid Prole and Reproductive Hormones.
eplasma testosterone levels remained within the reference
ranges for the hormone (10.3–27.4 nmol/L) (“Testosterone
(R-nr. 515)—Statens Serum Institut,” 2015) and did not show
any signicant dierence between the lean and overweight
chronic pain patients and their healthy controls. Both
chronic pain (LP and OP) subgroups demonstrated a ten-
dency towards lower average values of FSH and higher
values of LH compared with the control group (Figure 4).
Testosterone, FSH, and LH hormone levels did not show
a signicant interaction between pain and weight groups
(testosterone: p  0.87, FSH: p  0.63, and LH: p  0.87).
ere was a tendency towards higher cholesterol levels in
the LP and OP groups compared with LC and OC groups
(Table 5).e interaction between pain and weight groups for
the cholesterol levels was not signicant (cholesterol: p  0.70,
HDL: p  0.17, LDL: p  0.99, and triglyceride: p  0.96).
4. Discussion
e novelty of this study resides in investigating the in-
«uence of musculoskeletal chronic pain as a factor by itself,
or in combination with obesity, on sperm quality as a bio-
marker of fertility potential in men.
For the rst time, we investigated sperm motility in-
cluding detailed kinematic parameters, sperm morphology,
DNA fragmentation, and reproductive hormone levels as
biomarkers of male fertility in lean and overweight chronic
pain patients compared with lean and overweight healthy
controls.
Chronic pain and obesity have been advocated as in-
dependent risk factors for decreased serum testosterone
levels and altered sperm fertility potential [32–35]. In
chronic pain patients, the continuous nociceptive input can
cause alterations in the central processing of nociception and
maladaptive plasticity, resulting in increased pain sensitivity,
which is manifested on lower PPTvalues [36]. Our study also
demonstrated a tendency towards lower PPT values in the
chronic pain groups (LP and OP) compared with their
relative control groups (LC and OC), which is aligned with
some of the previously conducted studies demonstrating
decreased PPT values in chronic pain patients [36–40].
Chronic pain has also been considered as a drive for
stress response, and this recurrent stressor eect on the HPA
axis and GnRH axis has been demonstrated as a possible risk
factor for testosterone decrease [18, 21, 41, 42]. Adequate
testosterone levels have been shown to produce pain control
in males since this hormone is intricately involved in
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Figure 4: Estimated marginal means of reproductive hormones in overweight pain patient (OP), overweight control patient (OC), lean pain
patient (LP), and lean control patient (LC). Provided values are mean± standard deviation. Multivariate two-way analysis of variance
(MANOVA) was used to compare dierences in lipid prole. None of the ANOVA results are signicant.
Table 5: Lipid prole values in overweight pain patient (OP), overweight control patient (OC), lean pain patient (LP), and lean control
patient (LC). Provided values are median (25–75 percentiles). Multivariate two-way analysis of variance (MANOVA) was used to compare
dierences in lipid prole.
OP OC LP LC
Cholesterol (mmol/L) 4.3 (3.7–5.0) 4.3 (3.4–5.0) 5.0 (4.6–5.5) 4.4 (3.9–5.9)
Triglyceride 0.7 (0.5–1.0) 1.0 (0.7–1.4) 1.2 (0.9–1.6) 0.7 (0.6–1.3)
LDL (mg/dl) 2.6 (2.0–3.2) 2.6 (1.8–3.2) 3.3 (2.6–3.6) 2.5 (2.1–4.2)
HDL (mg/dl) 1.5 (1.3–1.8) 1.3 (1.1–1.4) 1.3 (1.1–1.4) 1.2 (1.1–1.7)
None of the ANOVA results are signicant.
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endogenous opioid activity [40, 43]. Low levels of plasma
testosterone result in elevated pain, which can be re:ected
on lower PPT values (higher muscle sensitivity), thereby
suggesting that testosterone plays a role in pain modulation
[18, 37, 43]. Despite previous reports supporting the role for
testosterone in dampening pain and raising the pain
threshold [44], no signi.cant correlation was observed be-
tween chronic pain and the hormonal pro.les in this study.
However, a decreased testosterone level was found in the
lean chronic pain patients (LP) compared with the related
healthymatched controls (LC) that could explain—at least in
part—some of our .ndings in the PPT assessments.
)e demonstrated tendency for lower PPT values (higher
sensitivity) in overweight chronic pain patients compared to
overweight healthy matched controls supports the previous
reports, suggesting that pain sensitivity may be mediated by
sociocultural, psychological, and biological factors [45].
Androgens also play an essential regulatory role in
spermatogenesis and the maturation and motility of the
spermatozoa during their transportation through the epi-
didymis and vas deferens [46]. It is known that sperm
motility characteristics have an in:uence on the fertilization
potential [31]. Furthermore, the sperm concentration has
also been found to be clearly associated with fertility and
conception rates [47]. Our results demonstrated that chronic
pain patients (LP) have lower values of sperm motility
parameters compared with the related healthy matched
controls (LC). A signi.cantly higher percentage of sperm
with progressive motility in the LC compared to the OC
group demonstrates the adverse e-ect of obesity on sperm
motility similar to previous reports [48]. On the other hand,
a signi.cantly higher percentage of sperm with progressive
motility in the LC compared to the LP group suggests a novel
negative e-ect of chronic pain on sperm motility in the lean
group. To date, there are a very limited number of studies
where chronic pain, reproductive hormones, and sperm
quality have been investigated together, and this limitation
makes it di<cult to compare or generalize the results of the
present study. Results from a meta-analysis by Fu et al. on
male fertility have indicated that chronic pelvic pain syn-
drome (CPPS) can signi.cantly reduce sperm concentration
and sperm kinematic parameters [41], which is in line with
our .ndings in patients with musculoskeletal pain.
)e OP group also demonstrates lower median values of
progressively motile sperm compared with the OC group;
however, the di-erence remained insigni.cant. Previous
studies have similarly reported that obesity has a negative
correlation with testosterone levels and consequently sperm
quality parameters, leading to decreased fertility potential
[7–9]. )e adverse e-ects of obesity on reproductive hor-
mones [49] and sperm motility could be considered as
confounding factors while trying to assess the e-ect of
chronic pain within the overweight groups a-ecting the
signi.cance of the reported results.
It may be speculated that even the insigni.cant change
of testosterone levels observed in this study may have an
e-ect on the maturation process of the sperm, thereby af-
fecting the spermmotility and kinematic parameters. On the
other hand, despite the demonstrated lower tendency in
testosterone levels for chronic pain patients compared with
the related healthy control group, it still remained within the
(lower) reference range, and therefore, a signi.cant di-er-
ence and more conclusive results could be expected in
a larger sample size. Prospective data are necessary to
con.rm these .ndings and explain the possible mechanism
involved in the e-ects of chronic pain onmale sperm quality,
especially the kinematic parameters.
Collectively, our results indicate that chronic pain has no
or minimal e-ect on sperm morphology and DNA frag-
mentation but signi.cantly reduces the percentage of pro-
gressively motile sperm in lean men and exerts a negative
e-ect on sperm concentration and kinematic parameters,
which can be considered as valuable biomarkers of male
fertility potential. However, the adverse overlapping e-ect of
obesity on sperm quality makes it di<cult to propose the
exact e-ect of musculoskeletal chronic pain on sperm quality
in overweight patients.
4.1. Strengths and Weaknesses. )e newer generation of
CASA systems used to assess detailed motility and kine-
matics of sperm samples in this study has the capability of
providing more precise and objective results than previous
generations [50, 51]. PPTmeasurements were performed by
the same investigator to minimize variations. Pain intensity
and quality, in the chronic pain subjects, were assessed by
using PPT, VAS, and a modi.ed version of the McGill Pain
Questionnaire (MPQ) to give a multidimensional perspec-
tive and a better understanding of the pain characteristics in
the recruited chronic pain patients. However, due to the
limited sample size of this study, .ndings should be inter-
preted cautiously. Future studies with a larger sample size
could provide more conclusive results in factors such as
changes of hormonal levels. Confounding factors caused by
the chronic pain, such as stress which is known to negatively
a-ect sperm quality [52], should also be considered in future
studies. Furthermore, measurement of some in:ammatory
and biochemical biomarkers could help clarify some of the
potential underlying mechanisms.
5. Conclusion
While sample size of this study may not preclude a type 2
error, the results strongly suggest that musculoskeletal
chronic pain has a signi.cantly negative in:uence on sperm
quality, seen as a signi.cantly lower percentage of pro-
gressively motile sperm in lean men.
Despite signi.cantly lower values of VCL, STR, and
WOB in the overweight men with chronic pain compared to
healthy controls, no signi.cant di-erence in the percentage
of sperm in di-erent motility groups was observed which
could be related to the overlapping negative in:uence of
obesity on the sperm parameters. Further investigation to
discriminate the e-ect of overweight and chronic pain in
cases where both complications exist is suggested to con.rm
this hypothesis. Further studies are also warranted to assess
the possible preventive or treatment strategies to break the
link between obesity, chronic pain, and sperm quality.
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